Literature DB >> 2544630

CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA.

K Kawa-Ha1, S Ishihara, T Ninomiya, K Yumura-Yagi, J Hara, F Murayama, A Tawa, K Hirai.   

Abstract

Lymphoproliferative disease of granular lymphocytes (LDGL) is a heterogeneous disorder and the pathogenesis is likely to be complex. Some patients with chronic active EBV (CAEBV) infection also have LDGL. To investigate the relationship between EBV infection and the pathogenesis of LDGL, we conducted a survey for EBV DNA sequences by Southern blot analysis of DNA obtained from the peripheral blood of seven patients with LDGL, including one with CAEBV infection. Interestingly, EBV DNA was detected in the sample from the patient with CAEBV infection, and in the samples from four other patients with CD3-LDGL. Moreover, a single band for the joined termini of the EBV genome was demonstrated in two samples, suggesting a clonal disorder of those LDGL. These findings strongly suggest that EBV may play a pathogenic role in some cases of LDGL.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544630      PMCID: PMC303951          DOI: 10.1172/JCI114168

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Remarkable depression of CD4+2H4+ T cells in severe chronic active Epstein-Barr virus infection.

Authors:  E Franco; K Kawa-Ha; S Doi; K Yumura; M Murata; S Ishihara; A Tawa; H Yabuuchi
Journal:  Scand J Immunol       Date:  1987-12       Impact factor: 3.487

2.  B-cell lymphoproliferation and lymphomagenesis are associated with clonotypic intracellular terminal regions of the Epstein-Barr virus.

Authors:  N A Brown; C R Liu; Y F Wang; C R Garcia
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2.

Authors:  K Kawa-Ha; E Franco; S Doi; K Yumura; S Ishihara; A Tawa; H Yabuuchi
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

Review 4.  Human natural killer cells: biologic and pathologic aspects.

Authors:  G Trinchieri; B Perussia
Journal:  Lab Invest       Date:  1984-05       Impact factor: 5.662

5.  The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.

Authors:  N Raab-Traub; K Flynn
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

6.  The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions.

Authors:  G Semenzato; F Pandolfi; T Chisesi; G De Rossi; G Pizzolo; R Zambello; L Trentin; C Agostini; E Dini; M Vespignani
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

7.  Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes.

Authors:  W C Chan; S Link; A Mawle; I Check; R K Brynes; E F Winton
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

8.  Concomitant rearrangements of T-cell beta- and gamma-chain genes in childhood T-lineage leukemia/lymphoma.

Authors:  K Ha-Kawa; K Yumura; J Hara; S Ishihara; H Yabuuchi
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

9.  Two tandemly organized human genes encoding the T-cell gamma constant-region sequences show multiple rearrangement in different T-cell types.

Authors:  M P Lefranc; T H Rabbitts
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

10.  Leu 11+ T gamma cell chronic lymphocytic leukemia with partially activated natural killer function and its further activation by recombinant IL2 in vitro.

Authors:  S Tagawa; Y Tokumine; E Ueda; K Waki; Y Kanayama; N Taniguchi; T Nakanishi; R Inoue; T Kitani
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

View more
  46 in total

1.  The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.

Authors:  R Longnecker; C L Miller; X Q Miao; A Marchini; E Kieff
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.

Authors:  A L Burkhardt; J B Bolen; E Kieff; R Longnecker
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Aggressive natural killer cell leukemia: report of a Chinese series and review of the literature.

Authors:  John Ryder; Xiaoqin Wang; Liming Bao; Sherilyn A Gross; Fu Hua; Richard D Irons
Journal:  Int J Hematol       Date:  2007-01       Impact factor: 2.490

4.  EBV-driven relapse of peripheral T-cell lymphoma, masquerading as a post transplant lymphoproliferative disorder following allo-SCT.

Authors:  C P Fox; M J Bishton; S O'Connor; S Hughes; J L Byrne; N Russell
Journal:  Bone Marrow Transplant       Date:  2013-08-12       Impact factor: 5.483

5.  Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.

Authors:  Renato Zambello; Gianpietro Semenzato
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

Review 6.  The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms).

Authors:  Robert R Maronpot; Abraham Nyska; Jennifer E Foreman; Yuval Ramot
Journal:  Crit Rev Toxicol       Date:  2016-06-09       Impact factor: 5.635

Review 7.  Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).

Authors:  Bradley M Haverkos; Carrie Coleman; Alejandro A Gru; Zenggang Pan; Jonathan Brammer; Rosemary Rochford; Anjali Mishra; Christopher C Oakes; Robert A Baiocchi; Aharon G Freud; Pierluigi Porcu
Journal:  Discov Med       Date:  2017-03       Impact factor: 2.970

Review 8.  Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders.

Authors:  M A Nalesnik; T E Starzl
Journal:  Transplant Sci       Date:  1994-09

9.  The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas.

Authors:  Tatsuharu Ohno; Yasunori Ueda; Ken-ichi Nagai; Takayuki Takahashi; Yoshiteru Konaka; Teruyuki Takamatsu; Takayo Suzuki; Masataka Sasada; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

10.  Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative disease.

Authors:  M Koyama; Y Takeshita; A Sakata; A Sawada; M Yasui; T Okamura; M Inoue; K Kawa
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.